DCLK1 autoinhibition and activation in tumorigenesis

Doublecortin-like kinase 1 (DCLK1) is upregulated in many tumors and is a marker for tumor stem cells. Accumulating evidence suggests DCLK1 constitutes a promising drug target for cancer therapy. However, the regulation of DCLK1 kinase activity is poorly understood, particularly the function of its...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Linna, Yang, Zejing, Guo, Wenhao, Wu, Chengyong, Liang, Shufang, Tong, Aiping, Cao, Zhongwei, Thorne, Rick F., Yang, Sheng-Yong, Yu, Yamei, Chen, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686072/
https://www.ncbi.nlm.nih.gov/pubmed/34977835
http://dx.doi.org/10.1016/j.xinn.2021.100191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686072/
https://www.ncbi.nlm.nih.gov/pubmed/34977835
http://dx.doi.org/10.1016/j.xinn.2021.100191

Ejemplares similares